Advertisement
SG Stocks

Q & M Dental Group (Singapore) Limited Surges 5.2% on Strong Earnings Growth

Key Points

QC7.SI stock surges 5.2% to S$0.605 on strong earnings momentum.

Net income climbs 27% with operating cash flow up 20.6%.

Meyka AI projects 27% upside to S$0.77 within 12 months.

Healthcare sector gains 13% as Q & M expands across Asia-Pacific.

Be the first to rate this article

Q & M Dental Group (Singapore) Limited’s QC7.SI stock surged 5.2% to S$0.605 today, marking strong intraday momentum on the Singapore Exchange. The healthcare provider’s gains reflect robust earnings growth, with net income climbing 27% year-over-year. The company operates 97 dental outlets across Singapore, 38 in Malaysia, and one in China, serving patients through comprehensive dental and medical services. Trading volume reached 826,100 shares, above the 30-day average, signaling investor confidence in the recovery trajectory.

Advertisement

QC7.SI Stock Performance and Technical Setup

QC7.SI stock trades at S$0.605, up 3 cents from yesterday’s close of S$0.575. The stock sits above its 50-day average of S$0.5681 and 200-day average of S$0.51602, confirming an uptrend. Year-to-date, QC7.SI has climbed 10%, while the 12-month return stands at 83.3%, reflecting strong recovery from pandemic lows.

Technical indicators show mixed signals. The RSI at 61.16 suggests moderate momentum without overbought conditions. The CCI reading of 214.63 indicates overbought territory, warning of potential pullback risk. Bollinger Bands position the stock near the middle band at S$0.59, with upper resistance at S$0.61 and support at S$0.57. Volume remains elevated at 1.44x the 30-day average, providing conviction to today’s move.

Earnings Growth Drives QC7.SI Valuation Expansion

Q & M Dental Group’s financial metrics reveal why QC7.SI stock attracted buyers today. Net income surged 27% to S$0.0066 per share, while operating income climbed 8.8%. Earnings per share (EPS) grew 27% year-over-year, though the stock’s PE ratio of 60.5x remains elevated relative to sector peers.

The company’s gross profit margin expanded 7.6%, demonstrating pricing power and operational efficiency. Operating cash flow jumped 20.6%, generating S$0.0278 per share, while free cash flow rose 20.3%. These cash generation improvements support the 1.36% dividend yield, making QC7.SI stock attractive for income-focused investors seeking healthcare exposure.

Healthcare Sector Momentum and Market Outlook

Singapore’s healthcare sector gained 13.04% over the past month, outpacing broader market indices. Q & M Dental Group benefits from rising demand for private dental services across Asia-Pacific. The company’s expansion into Malaysia and China positions it to capture growth from middle-class consumers seeking quality dental care.

Meyka AI rates QC7.SI stock with a grade of B, suggesting a HOLD recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company’s market cap of S$573 million reflects its position as a mid-cap healthcare provider. Meyka AI’s forecast model projects QC7.SI stock reaching S$0.77 within 12 months, implying 27% upside from current levels.

Q & M Dental Group (Singapore) Limited Price Forecast

Meyka AI’s forecast model projects QC7.SI stock at S$0.77 yearly, S$1.26 in three years, and S$1.75 in five years. These targets suggest sustained earnings growth and margin expansion. Current price of S$0.605 implies 27% upside to the one-year forecast, attractive for growth-oriented investors.

However, risks exist. The debt-to-equity ratio of 1.81x indicates moderate leverage, while the PE ratio of 60.5x prices in significant growth expectations. Receivables turnover of 3.25x shows collection efficiency, but days sales outstanding of 112 days suggests working capital management challenges. Track QC7.SI on Meyka for real-time updates and earnings announcements scheduled for August 17, 2026.

Advertisement

Final Thoughts

Q & M Dental Group’s 5.2% surge reflects strong earnings momentum and sector tailwinds in Singapore’s healthcare market. The company’s 27% net income growth, expanding margins, and robust cash generation justify investor optimism. With Meyka AI projecting 27% upside to S$0.77 within 12 months, QC7.SI stock offers compelling value for healthcare-focused portfolios. Monitor upcoming earnings in August for confirmation of sustained growth trajectory. These grades are not guaranteed and we are not financial advisors.

FAQs

Why did QC7.SI stock jump 5.2% today?

Q & M Dental Group’s net income surged 27% year-over-year with operating income up 8.8%. Strong cash flow and Singapore’s healthcare sector momentum drove investor buying.

What is the Meyka AI price target for QC7.SI stock?

Meyka AI projects QC7.SI at S$0.77 (12 months), S$1.26 (3 years), and S$1.75 (5 years), implying 27% upside from the current S$0.605 price.

Is QC7.SI stock a buy at S$0.605?

Meyka AI rates QC7.SI as HOLD with B grade. It offers 1.36% dividend yield and growth potential, but a 60.5x PE ratio warrants caution.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)